Human Health and Potential (HHP)

Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able to mount a strong immune response against infections.

Using a new nanomaterial, A*STAR researchers create a wound dressing that promotes healing and promises pain-free dressing changes for patients.

A*STAR researchers create a next-generation, ultrasensitive COVID-19 rapid test powered by gold nanoparticles.

A computational model developed at A*STAR provides insights on how molecular dynamics of proteins impact their function, unlocking new precision medicine opportunities.

A novel molecular mechanism by which a malarial parasite enters host cells may broaden possibilities in malaria vaccine development.

The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.

A*STAR researchers challenge existing theories around intestinal stem cell biology using a newly developed animal model of intestinal regeneration.

A phenomenon called superferromagnetism boosts the resolution of magnetic particle imaging.

A*STAR scientists developed self-sanitizing surfaces capable of eliminating microbes effectively within mere minutes.

SARS-CoV-2 genome structures and their interactions with human RNA are shown to be important in virus survival and pathogenicity.

A new smartphone app improves the reliability of on-site rapid COVID-19 colorimetric tests, paving the way for safe gatherings in the post-pandemic world.

Researchers have identified a stem cell marker that influences fat cell development, unlocking exciting therapeutic opportunities for chronic diseases.